EP1241945A4 - Immunotherapie et diagnostic du cancer utilisant du cytochrome p450 1b1 - Google Patents

Immunotherapie et diagnostic du cancer utilisant du cytochrome p450 1b1

Info

Publication number
EP1241945A4
EP1241945A4 EP00980436A EP00980436A EP1241945A4 EP 1241945 A4 EP1241945 A4 EP 1241945A4 EP 00980436 A EP00980436 A EP 00980436A EP 00980436 A EP00980436 A EP 00980436A EP 1241945 A4 EP1241945 A4 EP 1241945A4
Authority
EP
European Patent Office
Prior art keywords
cytochrome
diagnosis
cancer immunotherapy
immunotherapy
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00980436A
Other languages
German (de)
English (en)
Other versions
EP1241945A2 (fr
Inventor
Joachim L Schultze
Robert H Vonderheide
David Sherr
Lee M Nadler
Britta Maecker
Bergwelt-Baildon Michael Von
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boston University
Dana Farber Cancer Institute Inc
Original Assignee
Boston University
Dana Farber Cancer Institute Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boston University, Dana Farber Cancer Institute Inc filed Critical Boston University
Publication of EP1241945A2 publication Critical patent/EP1241945A2/fr
Publication of EP1241945A4 publication Critical patent/EP1241945A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/001154—Enzymes
    • A61K39/001157—Telomerase or TERT [telomerase reverse transcriptase]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • C12N9/0077—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14) with a reduced iron-sulfur protein as one donor (1.14.15)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/461—Cellular immunotherapy characterised by the cell type used
    • A61K39/4611—T-cells, e.g. tumor infiltrating lymphocytes [TIL], lymphokine-activated killer cells [LAK] or regulatory T cells [Treg]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/461—Cellular immunotherapy characterised by the cell type used
    • A61K39/4612—B-cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/461—Cellular immunotherapy characterised by the cell type used
    • A61K39/4615—Dendritic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/462—Cellular immunotherapy characterized by the effect or the function of the cells
    • A61K39/4622—Antigen presenting cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/4643—Vertebrate antigens
    • A61K39/4644—Cancer antigens
    • A61K39/464454—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/4643—Vertebrate antigens
    • A61K39/4644—Cancer antigens
    • A61K39/464454—Enzymes
    • A61K39/464457—Telomerase or [telomerase reverse transcriptase [TERT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
    • A61K2239/26—Universal/off- the- shelf cellular immunotherapy; Allogenic cells or means to avoid rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
EP00980436A 1999-11-15 2000-11-15 Immunotherapie et diagnostic du cancer utilisant du cytochrome p450 1b1 Withdrawn EP1241945A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16559099P 1999-11-15 1999-11-15
US165590P 1999-11-15
PCT/US2000/031513 WO2001035810A2 (fr) 1999-11-15 2000-11-15 Immunotherapie et diagnostic du cancer utilisant du cytochrome p450 1b1

Publications (2)

Publication Number Publication Date
EP1241945A2 EP1241945A2 (fr) 2002-09-25
EP1241945A4 true EP1241945A4 (fr) 2005-08-17

Family

ID=22599560

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00980436A Withdrawn EP1241945A4 (fr) 1999-11-15 2000-11-15 Immunotherapie et diagnostic du cancer utilisant du cytochrome p450 1b1

Country Status (3)

Country Link
EP (1) EP1241945A4 (fr)
CA (1) CA2390882A1 (fr)
WO (1) WO2001035810A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1404841B1 (fr) * 2000-10-31 2011-08-17 Eisai Inc. Acide nucleique de cyp1b1 et ses procedes d'utilisation
GB0223696D0 (en) * 2002-10-14 2002-11-20 Ml Lab Plc Improved immunotherapy
WO2004067549A2 (fr) * 2003-01-31 2004-08-12 Max-Delbrück-Centrum für Molekulare Medizin Peptides diriges contre des autoanticorps resultant de l'intolerance au froid, et leur utilisation

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997012246A1 (fr) * 1995-09-25 1997-04-03 University Of Aberdeen Proteine p450 specifique de tumeurs
WO2000056773A1 (fr) * 1999-03-19 2000-09-28 The University Court Of The University Of Aberdeen Anticorps specifiques de cyp1b1

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7851591B1 (en) * 1998-10-29 2010-12-14 Dana Farber Cancer Institute, Inc. Cancer immunotherapy and diagnosis using universal tumor associated antigens, including hTERT

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997012246A1 (fr) * 1995-09-25 1997-04-03 University Of Aberdeen Proteine p450 specifique de tumeurs
WO2000056773A1 (fr) * 1999-03-19 2000-09-28 The University Court Of The University Of Aberdeen Anticorps specifiques de cyp1b1

Also Published As

Publication number Publication date
WO2001035810A3 (fr) 2002-01-10
EP1241945A2 (fr) 2002-09-25
WO2001035810A2 (fr) 2001-05-25
CA2390882A1 (fr) 2001-05-25

Similar Documents

Publication Publication Date Title
AU3617600A (en) Human breast and ovarian cancer associated gene sequences and polypeptides
AU2002316576A1 (en) Diagnostic and screening methods for bladder cancer
EP1474528A4 (fr) Procedes de diagnostic du cancer de la prostate, compositions et procedes de criblage de modulateurs du cancer de la prostate
GB9917746D0 (en) Distortion reduction
GB2371747B (en) Metal-containing compositions, preparations and uses
EP1372736A4 (fr) Preparations anti-neovaisseaux destinees au traitement anticancereux
EP1511476A4 (fr) Ligands macrocycliques pendants de type scorpionates, complexes et compositions contenant ces derniers, et leurs procedes d'utilisation
AU6476000A (en) Mouse having human cytochrome p450 transferred therein
IL131662A0 (en) Cytochrome p450 monooxygenases
AU3391200A (en) Compositions and methods for breast cancer therapy and diagnosis
PL335643A1 (en) P450 cytochrome mono-oxygenases
AU2608201A (en) Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
AU2002342053A1 (en) Pancreatic cancer diagnosis and therapies
EP1241945A4 (fr) Immunotherapie et diagnostic du cancer utilisant du cytochrome p450 1b1
AUPO887297A0 (en) Cytochrome p450 reductase from poppy plants
AU1083501A (en) Antibiotic-metal complex and methods
AU5909400A (en) Slide lock and report cover
GB9928720D0 (en) Distortion reduction
AU7634900A (en) Digital rosary
AU2001271284A1 (en) Compositions and methods for the therapy and diagnosis of pancreatic cancer
AU2001283463A1 (en) Methods of diagnosis of cancer and screening for cancer modulators
MXPA02004785A (es) Citocromo p450 oxigenasas y sus usos.
AU5632500A (en) Cancer associated antigens and uses therefor
AU2002305138A1 (en) Methods and materials for cancer treatment
AU3742500A (en) Ligands, transition metal complexes and methods of using same

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20020614

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

RIN1 Information on inventor provided before grant (corrected)

Inventor name: MAECKER, BRITTA

Inventor name: SHERR, DAVID

Inventor name: VON BERGWELT-BAILDON, MICHAEL

Inventor name: NADLER, LEE, M.

Inventor name: SCHULTZE, JOACHIM, L.

Inventor name: VONDERHEIDE, ROBERT, H.

RIC1 Information provided on ipc code assigned before grant

Free format text: 7A 01N 63/00 A, 7A 61K 39/00 B, 7C 12N 1/20 B, 7C 12N 15/85 B

RIN1 Information on inventor provided before grant (corrected)

Inventor name: VON BERGWELT-BAILDON, MICHAEL

Inventor name: SCHULTZE, JOACHIM, L., ATABIS GMBH

Inventor name: NADLER, LEE, M.

Inventor name: MAECKER, BRITTA

Inventor name: SHERR, DAVID

Inventor name: VONDERHEIDE, ROBERT, H.

A4 Supplementary search report drawn up and despatched

Effective date: 20050704

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20060515